| Followers | 226 |
| Posts | 13536 |
| Boards Moderated | 0 |
| Alias Born | 03/15/2013 |
Tuesday, May 07, 2024 7:36:59 PM
Recent VNDA News
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 01/21/2026 05:26:45 PM
- Vanda shares slide after FDA turns down jet lag use for HETLIOZ • IH Market News • 01/08/2026 12:56:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2026 12:09:31 PM
- Vanda Pharmaceuticals Announces Receipt of FDA Decision Letter on HETLIOZ® Supplemental New Drug Application for Jet Lag Disorder • PR Newswire (US) • 01/08/2026 12:00:00 PM
- Vanda Pharmaceuticals Announces FDA Approval of NEREUS™ (tradipitant) for the Prevention of Vomiting Induced by Motion: A Historic Scientific Milestone in the Prevention of Motion Sickness • PR Newswire (US) • 12/30/2025 11:13:00 PM
- Vanda Announces Submission of Biologics License Application to the FDA for Imsidolimab for the Treatment of Generalized Pustular Psoriasis • PR Newswire (US) • 12/15/2025 12:00:00 PM
- Vanda Pharmaceuticals Announces Participation in the J.P. Morgan Healthcare Conference • PR Newswire (US) • 12/11/2025 10:02:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2025 09:39:04 PM
- FDA Lifts Partial Clinical Hold on Tradipitant for Motion Sickness • PR Newswire (US) • 12/04/2025 09:21:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2025 12:06:24 PM
- Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness • PR Newswire (US) • 11/28/2025 12:00:00 PM
- Vanda Pharmaceuticals Reports Positive Results for Tradipitant in Preventing GLP-1 Induced Nausea and Vomiting • PR Newswire (US) • 11/17/2025 11:37:00 PM
- Vanda Pharmaceuticals Announces Participation in the Stifel 2025 Healthcare Conference • PR Newswire (US) • 11/05/2025 10:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/30/2025 11:23:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/29/2025 08:08:14 PM
- Vanda Pharmaceuticals Reports Third Quarter 2025 Financial Results • PR Newswire (US) • 10/29/2025 08:01:00 PM
- Vanda Pharmaceuticals to Announce Third Quarter 2025 Financial Results on October 29, 2025 • PR Newswire (US) • 10/22/2025 08:30:00 PM
- Monumental Sports & Entertainment Taps D.C.'s Own Vanda Pharmaceuticals as Founding Partner to Help Drive the Creation of Brand-New Downtown Arena • PR Newswire (US) • 10/08/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2025 09:10:10 PM
- Vanda Pharmaceuticals Announces Collaborative Framework for Resolution of Disputes with the U.S. Food and Drug Administration • PR Newswire (US) • 10/01/2025 09:02:00 PM
- Vanda Pharmaceuticals announces the publication in PLOS One of an article titled "Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial" • PR Newswire (US) • 09/25/2025 12:00:00 PM
- Vanda Pharmaceuticals Announces Participation at September 2025 Investor Conferences • PR Newswire (US) • 08/28/2025 09:23:00 PM
- Vanda Pharmaceuticals Jumps After FDA Grants Orphan Drug Status for PV Therapy • IH Market News • 08/28/2025 12:52:47 PM
- Vanda Pharmaceuticals Announces FDA Granted Orphan Drug Designation for VGT-1849B, a Novel and Selective Candidate for the Treatment of Polycythemia Vera • PR Newswire (US) • 08/28/2025 11:00:00 AM
- Vanda Pharmaceuticals Shares Climb After Court Reverses FDA Decision • IH Market News • 08/18/2025 02:19:13 PM
FEATURED Cannabix Marijuana Breath Test Featured on the Cover of AlcoPro's 2026 Product Catalog • Jan 22, 2026 8:52 AM
Metavesco Congratulates DeFi Dev Corp on Becoming the Second Publicly Traded Company to Launch a Memecoin • MVCO • Jan 22, 2026 6:04 PM
Rainmaker Worldwide Strengthens North American Growth Pipeline With Affiliate Partnership Supporting Ontario's Housing Expansion • RAKR • Jan 22, 2026 10:19 AM
From Permits to Gold Pour: Why Readiness Matters • LFLR • Jan 22, 2026 9:00 AM
Envirotech Vehicles Reaffirms Momentum With AZIO AI and Provides Update on Nasdaq Compliance Process • EVTV • Jan 21, 2026 1:25 PM
Rainmaker Worldwide Expands U.S. Operations With ATMOCELL 5K and R/OCell® Deployments in the Permian Basin • RAKR • Jan 20, 2026 11:15 AM
